Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


Neurocrine Biosciences Inc (NBIX) reported a profit for its fourth quarter that increased from the same period last year.


RTTNews | Feb 4, 2021 04:06PM EST

16:05 Thursday, February 4, 2021 (RTTNews.com) - Neurocrine Biosciences Inc (NBIX) reported a profit for its fourth quarter that increased from the same period last year.

The company's earnings came in at $347.9 million, or $3.58 per share. This compares with $34.0 million, or $0.35 per share, in last year's fourth quarter.

Excluding items, Neurocrine Biosciences Inc reported adjusted earnings of $88.1 million or $0.91 per share for the period.

Analysts had expected the company to earn $0.54 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 1.6% to $247.9 million from $244.1 million last year.

Neurocrine Biosciences Inc earnings at a glance:

-Earnings (Q4): $88.1 Mln. vs. $102.2 Mln. last year.-EPS (Q4): $0.91 vs. $1.05 last year.-Analysts Estimate: $0.54-Revenue (Q4): $247.9 Mln vs. $244.1 Mln last year.

Read the original article on RTTNews ( https://www.rttnews.com/3167069/neurocrine-biosciences-inc-q4-adjusted-earnings-beat-estimates.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC